Inventor · disambiguated record
Karin R. Tietje
Also filed as: TIETJE KARIN · TIETJE KARIN R · TIETJE KARIN ROSEMARIE
20 granted patents·6 pending applications·367 citations·filing 1974–2015
95Inventor score
Top patents by PatentIndex Score
26 records- 0194US4167565AAdenosine-5'-carboxamides and method of useABBOTT LAB·Filed 1976·Granted Sep 11, 1979·50 cites·15 claims
- 0293US7875639B2Compounds as cannabinoid receptor ligands and uses thereofABBOTT LAB·Filed 2007·Granted Jan 25, 2011·26 cites·14 claims
- 0393US6809105B2Diazabicyclic central nervous system active agentsABBOTT LAB·Filed 2001·Granted Oct 26, 2004·53 cites·20 claims
- 0492US7750039B2Indoles are cannabinoid receptor ligandsABBOTT LAB·Filed 2009·Granted Jul 6, 2010·17 cites·5 claims
- 0591US7560481B2Indoles are cannabinoid receptor ligandsABBOTT LAB·Filed 2005·Granted Jul 14, 2009·17 cites·14 claims
- 0691US7135484B2Azabicyclic compounds are central nervous system active agentsABBOTT LAB·Filed 2003·Granted Nov 14, 2006·26 cites·5 claims
- 0790US7399765B2Substituted diazabicycloalkane derivativesABBOTT LAB·Filed 2004·Granted Jul 15, 2008·33 cites·16 claims
- 0883US4081447A5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereofABBOTT LAB·Filed 1975·Granted Mar 28, 1978·19 cites·2 claims
- 0979US8119635B2Diazabicyclic central nervous system active agentsSCHRIMPF MICHAEL R·Filed 2009·Granted Feb 21, 2012·2 cites·9 claims
- 1074US7319106B2Diazabicyclic central nervous system active agentsABBOTT LAB·Filed 2004·Granted Jan 15, 2008·5 cites·20 claims
- 1173US5792767ABicyclic substituted hexahydrobenz e! isoindole alpha-1 adrenergic antagonistsABBOTT LAB·Filed 1995·Granted Aug 11, 1998·37 cites·6 claims
- 1271US5288749ATertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitorsABBOTT LAB·Filed 1991·Granted Feb 22, 1994·26 cites·13 claims
- 1370US5597823ATricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonistsABBOTT LAB·Filed 1995·Granted Jan 28, 1997·31 cites·17 claims
- 1469US7872010B2Substituted diazabicycloalkane derivatives having affinity for nicotinic acetylcholine receptorsABBOTT LAB·Filed 2008·Granted Jan 18, 2011·0 cites·20 claims
- 1569US5521181ABicyclic substituted hexahydrobenz[e]isoindole α-1 adrenergic antagonistsABBOTT LAB·Filed 1995·Granted May 28, 1996·15 cites·20 claims
- 1668US7598236B2Diazabicyclic central nervous system active agentsABBOTT LAB·Filed 2007·Granted Oct 6, 2009·0 cites·19 claims
- 1765US3992531A2-Substituted adenosine-5'-carboxylates in the treatment of anginal painABBOTT LAB·Filed 1974·Granted Nov 16, 1976·10 cites·2 claims
- 1858US2012208820A1Diazabicyclic central nervous system active agentsSCHRIMPF MICHAEL R·Filed 2012·Application pending·0 cites
- 1954US2006287290A1Azabicyclic compounds are central nervous system active agentsDART MICHAEL J·Filed 2006·Application pending·0 cites
- 2052US8841334B2Compounds as cannabinoid receptor ligands and uses thereofFLORJANCIC ALAN S·Filed 2008·Granted Sep 23, 2014·0 cites·18 claims
- 2149US9006275B2Compounds as cannabinoid receptor ligands and uses thereofFLORJANCIC ALAN S·Filed 2010·Granted Apr 14, 2015·0 cites·2 claims
- 2249US2011065685A1Novel indoles are cannabinoid receptor ligandsABBOTT LAB·Filed 2010·Application pending·0 cites
- 2346US2015231141A1Novel compounds as cannabinoid receptor ligands and uses thereofABBVIE INC·Filed 2015·Application pending·0 cites
- 2445US8546583B2Compounds as cannabinoid receptor ligands and uses thereofFLORJANCIC ALAN S·Filed 2007·Granted Oct 1, 2013·0 cites·5 claims
- 2543US2005065178A1Substituted diazabicycloakane derivativesFiled 2003·Application pending·0 cites
- 2640US2004044029A1Azabicyclic compounds are central nervous system active agentsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karin R. Tietje files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →